Synthesis and biological evaluation of new derivatives of emodin

被引:52
|
作者
Teich, L
Daub, KS
Krügel, V
Nissler, L
Gebhardt, R
Eger, K
机构
[1] Univ Leipzig, Inst Pharm, Fak Biowissensch Pharm & Psychol, D-04103 Leipzig, Germany
[2] Univ Leipzig, Fak Med, Inst Biochem, D-04103 Leipzig, Germany
关键词
D O I
10.1016/j.bmc.2004.08.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs containing an anthraquinone moiety such as daunorubicin (Daunoblastin) and mitoxantrone (Onkotrone) constitute some of the most powerful cytostatics. They suppress tumor growth mainly by intercalation into DNA and inhibition of topoisomerase II. and are suspected to generate free radicals leading to DNA strand scission. We established a novel strategy for obtaining new highly functionalized derivatives of emodin (1,3,8-trihydroxy-6-methyl-anthraquinone). Using emodin, DIB, and an appropriate amine as starting materials, we obtained a wide range of emodin-related structures by one-pot synthesis. Several of these derivatives showed stronger cytotoxic and cytostatic activity than emodin. In particular, compound 6 was highly effective on the HepG2 tumor cell line, but did not show any cytotoxicity on normal hepatocytes. In addition to this favorable feature, compound 6 revealed interesting binding properties to a recombinant fragment of the multi-drug-resistance transporter, pgp, and reversed the multi-drug-resistance phenotype of H4-II-E cells, thus making this compound a promising potential anti-tumor drug. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5961 / 5971
页数:11
相关论文
共 50 条
  • [41] Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents
    Shang, Ruo-Feng
    Wang, Guan-Hua
    Xu, Xi-Ming
    Liu, Si-Jie
    Zhang, Chao
    Yi, Yun-Peng
    Liang, Jian-Ping
    Liu, Yu
    MOLECULES, 2014, 19 (11) : 19050 - 19065
  • [42] Synthesis and biological evaluation of new 4-thiazolidinone derivatives
    Guzel, Ozlen
    Salman, Aydin
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (04) : 1015 - 1023
  • [43] Synthesis and biological evaluation of some new fused quinazoline derivatives
    Ibrahim, SS
    AbdelHalim, AM
    Gabr, Y
    ElEdfawy, S
    AbdelRahman, RM
    JOURNAL OF CHEMICAL RESEARCH-S, 1997, (05): : 154 - 155
  • [44] New benzimidazole derivatives: Design, synthesis, docking, and biological evaluation
    Obaid, Rami J.
    ARABIAN JOURNAL OF CHEMISTRY, 2023, 16 (02)
  • [45] Design, Synthesis, Biological Evaluation of New Porphyrin and Metalloporphyrin Derivatives
    Alsantali, Reem, I
    El-badrawy, Afnan M.
    Alsharif, Meshari A.
    Ahmed, Saleh A.
    Fadda, Ahmed A.
    POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (07) : 6697 - 6715
  • [46] Synthesis of Some New Thiazole Derivatives and Their Biological Activity Evaluation
    Yurttas, Leyla
    Ozkay, Yusuf
    Gencer, Hulya Karaca
    Acar, Ulviye
    JOURNAL OF CHEMISTRY, 2015, 2015
  • [47] Synthesis of new derivatives of boehmeriasin A and their biological evaluation in liver cancer
    Guzelcan, Ece Akhan
    Baxendale, Ian R.
    Cetin-Atalay, Rengul
    Baumann, Marcus
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 166 : 243 - 255
  • [48] New desulfured troglitazone derivatives: Improved synthesis and biological evaluation
    Dupommier, Dorian
    Muller, Claire
    Comoy, Corinne
    Mazerbourg, Sabine
    Bordessa, Andrea
    Piquard, Eline
    Pawlak, Manon
    Piquard, Flavian
    Martin, Helene
    De Fays, Elia
    Grandemange, Stephanie
    Flament, Stephane
    Boisbrun, Michel
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [49] Synthesis and biological evaluation of scopoletin derivatives
    Cai, Xueting
    Yang, Jie
    Zhou, Jinpei
    Lu, Wuguang
    Hu, Chunping
    Gu, Zhenhua
    Huo, Jiege
    Wang, Xiaoning
    Cao, Peng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (01) : 84 - 92
  • [50] Synthesis and biological evaluation of thiosemicarbazone derivatives
    Dogan, Murat
    Kocyigit, Umit M.
    Gurdere, Meliha Burcu
    Ceylan, Mustafa
    Budak, Yakup
    MEDICAL ONCOLOGY, 2022, 39 (10)